Estrogen-signaling pathway: A link between breast cancer and melatonin oncostatic actions
- 1 January 2006
- journal article
- review article
- Published by Elsevier BV in Cancer Detection Prevention
- Vol. 30 (2), 118-128
- https://doi.org/10.1016/j.cdp.2006.03.002
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Melatonin inhibits the growth of DMBA-induced mammary tumors by decreasing the local biosynthesis of estrogens through the modulation of aromatase activityInternational Journal of Cancer, 2005
- Melatonin increases p53 and p21WAFl expression in MCF-7 human breast cancer cells in vitroLife Sciences, 1999
- Oestrogens, Beatson and endocrine therapyEndocrine-Related Cancer, 1997
- Melatonin inhibits dna synthesis in mcf-7 human breast cancer cells in vitroLife Sciences, 1996
- Modulation of the length of the cell cycle time of MCF-7 human breast cancer cells by melatoninLife Sciences, 1996
- Interaction between melatonin and estradiol on morphological and morphometric features of MCF-7 human breast cancer cellsJournal of Pineal Research, 1994
- Melatonin inhibits mammary gland development in female miceJournal of Pineal Research, 1992
- Decreased Nocturnal Plasma Melatonin Peak in Patients with Estrogen Receptor Positive Breast CancerScience, 1982
- Urinary melatonin levels in human breast cancer patientsJournal of Neural Transmission, 1981
- ISOLATION OF MELATONIN, THE PINEAL GLAND FACTOR THAT LIGHTENS MELANOCYTES1Journal of the American Chemical Society, 1958